0001477932-22-000447.txt : 20220126 0001477932-22-000447.hdr.sgml : 20220126 20220126165455 ACCESSION NUMBER: 0001477932-22-000447 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20220120 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220126 DATE AS OF CHANGE: 20220126 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AmpliTech Group, Inc. CENTRAL INDEX KEY: 0001518461 STANDARD INDUSTRIAL CLASSIFICATION: COMMUNICATIONS EQUIPMENT, NEC [3669] IRS NUMBER: 274566352 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40069 FILM NUMBER: 22558642 BUSINESS ADDRESS: STREET 1: 620 JOHNSON AVENUE CITY: BOHEMIA STATE: NY ZIP: 11716 BUSINESS PHONE: 631-521-7831 MAIL ADDRESS: STREET 1: 620 JOHNSON AVENUE CITY: BOHEMIA STATE: NY ZIP: 11716 FORMER COMPANY: FORMER CONFORMED NAME: BAYVIEW ACQUISITION CORP DATE OF NAME CHANGE: 20110418 8-K 1 ampg_8k.htm FORM 8-K ampg_8k.htm

  

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (date of earliest event reported): January 20, 2022

 

AmpliTech Group, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Nevada

 

000-54355

 

92-4566352

(State of incorporation)

 

(Commission File Number)

 

(IRS Employer Identification No.)

 

620 Johnson Avenue

Bohemia, NY 11716

(Address of principal executive offices)

 

(631)-521-7831

(Registrant’s telephone number, including area code)

 

________________________________________________ 

(Former Name or former address if changed from last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange on

which registered

Common Stock, par value $0.001 per share

 

AMPG

 

The Nasdaq Stock Market LLC

Warrants to Purchase Common Stock

 

AMPGW

 

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On January 20, 2022, AmpliTech Group, Inc. (the “Company”) entered into director agreements (the “Director Agreements”) with each of Matthew Kappers, Andrew Lee and Daniel Mazziota, current directors of the Company.  The Director Agreements, substantially in the form attached hereto as Exhibit 10.1, have a one year term and provide, among other things, that each of the directors shall be entitled to fees for attendance at virtual meetings, reimbursement of expenses for attending meetings and a grant of 15,000 restricted stock units pursuant to the Company’s 2020 Equity Incentive Plan.  The Director Agreements also provide for termination upon notice by either party.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

10.1

 

Form of Director Agreement, by and between the applicable director and the Company, dated January 20, 2022.

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Amplitech Group Inc.

 

 

 

 

 

Date: January 26, 2022

By:

/s/ Fawad Maqbool

 

 

Name:

Fawad Maqbool

 

 

Title:

President

 

 

 

3

 

EX-10.1 2 ampg_ex101.htm DIRECTOR AGREEMENT ampg_ex101.htm

EXHIBIT 10.1

  

DIRECTOR AGREEMENT

 

DIRECTOR AGREEMENT, dated as of January 20, 2022, by and between Amplitech Group, Inc., a Nevada corporation (the “Company”), and [DIRECTOR] (the “Director”).

 

W I T N E S S E T H:

 

WHEREAS, the Company wishes to engage the Director and the Director is willing to accept such engagement upon the terms and conditions hereinafter set forth.

 

NOW, THEREFORE, in consideration of the mutual covenants set forth herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:

 

1. Services. Upon the terms and subject to the conditions of this Agreement and with effect from the Effective Date (as defined below), the Company hereby engages the Director to act as a Member of the Board of Directors of the Company, and the [COMMITTEE NAME] Committee Chairman and provide services on the terms and conditions provided in this Agreement. The Director agrees to devote appropriate time and attention to the execution of the services to be provided by the Director hereunder, which shall include the services listed on Exhibit A; or such other services as the Company and the Director may reasonably agree (hereinafter the services to be provided by the Director hereunder are referred to as the “Services”).

 

2. Term of Engagement. The term of the Director’s engagement by the Company under this Agreement shall commence on the 20th day of January 2022 (the “Effective Date”) and shall terminate on the day 1 year(s) (the “Contract Period”) from the date thereof (the “Termination Date”).

 

3. Independent Contractor. The Director would be an independent contractor, not an employee or agent of the Company.

 

4. Compensation.

 

(a) Meetings. The Director shall be re-imbursed for all expenses related to attending any Board meeting personally attended, and will be paid a fee for any virtual meetings.

 

(b) Restricted Stock Units. The Director shall be issued 15,000 restricted stock units (“RSU’s”), pursuant to the Company’s 2020 Equity Incentive Plan.

 

(c) Benefits. During the Contract Period, the Director shall not receive or be eligible to participate in the Company’s benefit programs in effect for the employees of the Company as in effect from time to time, on and after the Effective Date.

 

 
- 1 -

 

 

(d) Expenses. The Company shall reimburse the Director for all reasonable business travel expenses previously authorized in writing by the Company and reasonably and necessarily incurred by the Director in the performance of his duties, responsibilities, and authorities hereunder.

 

5. Termination Provisions. The Contract Period shall terminate, and the Director’s engagement hereunder shall cease, effective upon the date of any of the occurrences set forth below (the “Termination Date”):

 

(a) Termination By Reason of Timing. The Contract Period shall terminate one year from the Effective Date (such date being the Termination Date).

 

(b) Termination By Reason of Permanent Disability. If at any time during the Contract Period the Company reasonably determines that the Director has been or will be unable, as a result of physical or mental illness or incapacity, to perform his duties hereunder for one year, the Contract Period may be terminated by the Company upon written notice to the Director.

 

(c) Termination with Notice. Either party hereto may terminate the Contract Period for any reason upon thirty (30) days written notice to the other party. All Compensation earned upon such Termination Date shall be due and payable.

 

(d) Termination By Reason of Death. The Contract Period shall automatically terminate on the date of the Director’s death (such date being the Termination Date).

 

(e) Termination shall not occur if the parties hereto mutually agree to extend the term hereof, or if the terms hereof are renegotiated in good faith by the parties hereto.

 

6. Covenants of the Director.

 

(a) Non-solicitation of Employees of the Company, Directors of the Company or Customers or Suppliers of the Company. During the Contract Period and for three (3) year following the Contract Period (the “Subject Period”), the Director shall not, directly or indirectly, on behalf of any business, firm, corporation, partnership, person, proprietorship or other entity, incorporated or otherwise, and shall use his best efforts to cause each business, firm, corporation, partnership, person, proprietorship and other entity with which he is or shall become associated in any capacity not to, (i) solicit for employment, employ or otherwise engage any employee or Director of the Company, without the written consent of the Company, or (ii) except in connection with the performance of his duties hereunder and in accordance herewith, solicit, interfere with, endeavor to entice away from the Company or communicate with regarding the business of the Company any customer or supplier of the Company. The Director acknowledges and agrees in connection with the foregoing that the identities of the Company’s employees, Directors, customers, suppliers and clients and other information gained during his period of employment with the Company with respect thereto is Confidential Information (as more fully defined in paragraph (b) below) of the Company.

 

 
- 2 -

 

 

(b) Confidentiality. During the Subject Period and at all times thereafter, the Director agrees and acknowledges that the Confidential Information (as defined below) of the Company is valuable, special and unique to its business; that such business depends on such Confidential Information; and that the Company wishes to protect such Confidential Information by keeping it confidential for the exclusive use and benefit of the Company. The Director further acknowledges that any use by him of the Confidential Information other than in strict accordance with the terms of this Agreement would be wrongful and would cause the Company irreparable injury. Based upon the foregoing, with respect to such Confidential Information, the Director agrees:

 

(i)   to keep any and all Confidential Information in trust for the sole use and benefit of the Company;

 

(ii) except as required by applicable law or as required in furtherance of the business of the Company in accordance with the terms hereof, not to use or disclose or reproduce, directly or indirectly, any Confidential Information of the Company;

 

(iii) to take all steps necessary or reasonably requested by the Company to ensure that all Confidential Information is kept confidential for the sole use and benefit of the Company; and

 

(iv) in the event the Director’s employment with the Company terminates for any reason whatsoever or at any time that the Company may in writing request, to deliver promptly to the Company all materials constituting Confidential Information (including all written, graphic, facsimile, encoded or recorded copies or duplicates thereof or notes regarding the same) of the Company that are in his possession or under his control without making or retaining any written graphic, facsimile, encoded or recorded copy or extract from such materials.

 

For purposes of this Section 6, “Confidential Information” means any and all information developed by or for or possessed by the Company prior to or during the Contract Period that is (A) not generally known in any industry in which the Company does business as of the date hereof or during the Contract Period or (B) not publicly available (including for this purpose information that is publicly available because of a breach by the Director of the provisions hereof). Confidential Information includes, but is not limited to, the information identified in Section 6(a) above (including, without limitation, personnel records and applications, employment and other Director agreements, medical records, Director appraisals, reviews and evaluations, general wage and salary rates and individual salaries and bonuses and plans and records relating thereto, numbers of Directors in departments and divisions, Director benefit plans and incentive plans), and any and all other information developed by or for or possessed by the Company concerning information technology, marketing and sales methods, concepts, materials, products, processes, procedures, formulae, compounds, formulations, models, innovations, discoveries, improvements, inventions, protocols, computer programs, records, data, know-how, techniques, designs, machinery, devices, research and development projects, data, preparations, business forms, strategies, plans for development of products, services or expansion into new areas or markets, internal operations, product price lists, forecasts, projections, financial information (including the revenues, costs or profits associated with the products of the Company) and any other trade secrets and proprietary information of any type owned by or pertaining to the Company, together with all written, graphic, facsimile, encoded, recorded and other materials relating to all or any part of the same.

 

 
- 3 -

 

 

(c) Noncompetition, etc. During the Contract Period and the extension thereof, the Director shall not, directly or indirectly, engage in or be associated with, whether as a director, officer, employee, agent, Director, shareholder, partner, owner, independent contractor or otherwise, any business, firm, corporation, partnership, person, proprietorship or other entity, incorporated or otherwise (other than the Company), which is conducting, or plans to conduct, any business which competes with or will compete with, in the United States, (i) the business of the Company as constituted during the Contract Period, or (ii) the products of the Company manufactured, sold or under development by the Company during the Contract Period; provided, however, nothing herein shall prohibit the Director from being a shareholder in any entity that competes with the Company so long as the Director does not control such entity and does not hold more than a five percent (5%) equity interest therein.

 

(d) Compliance With Laws. In performing his duties hereunder the Director agrees to comply with all applicable governmental laws, rules and regulations and all applicable policies and procedures of the Company.

 

(e) Miscellaneous. For purposes of Section 6 hereof, the term “Director” shall include the Director’s affiliates and advisors.

 

7. Representations and Warranties.

 

(a) The Company. The Company hereby represents and warrants to the Director as follows:

 

(i)   the Company is duly incorporated, validly existing and in good standing under the laws of the State of Nevada; and

 

(ii)  this Agreement has been duly authorized, executed and delivered by the Company.

 

(b) The Director. The Director hereby represents and warrants to the Company as follows:

 

(i)   the Director has full legal capacity to enter into this Agreement;

 

(ii) the execution, delivery and performance by the Director of this Agreement will not conflict with or result in a breach of any of the terms, conditions or provisions of, or constitute (with due notice or lapse of time or both) a default under, any agreement or instrument to which the Director is a party or by which he is bound;

 

 
- 4 -

 

 

(iii) this Agreement has been duly executed and delivered by the Director; and

 

(iv) the Director has made such investigations of the business and properties of the Company as he deems necessary or appropriate before entering into this Agreement and has been given a sufficient amount of time to review this Agreement with counsel and other professionals of his choice and has done so to the extent he desires.

 

Without limiting clause (ii) above, the Director hereby represents and warrants that he is not bound by the terms of any agreement with any other party to refrain from using or disclosing any trade secret or confidential or proprietary information in the course of his employment with the Company or to refrain from competing, directly or indirectly, with the business of such other party. The Director further represents and warrants that his performance of all the terms of this Agreement and as a Director of the Company does not and will not breach any agreement to keep in confidence proprietary information, knowledge or data acquired by him in confidence or in trust prior to his employment with the Company.

 

8. Director and Officer Insurance. The Company shall make all commercially reasonable efforts to procure suitable director and officer insurance for a company of substantially similar size and position. Such insurance shall cover and include the Director.

 

9. Indemnification. The Company shall indemnify the Director and each of his agents against any loss, liability, claim, damage, or expense arising from the actions or inactions of the Company (or any of its officers and directors), including, but not limited to, any and all out of pocket expense and reasonable attorneys’ fees whatsoever reasonably incurred in investigating, preparing, or defending against any litigation, commenced or threatened, or any third party claim whatsoever), to which the Director may become subject arising out of or based on any actions or inactions or operations of the Company (or any of its officers and directors), to the fullest extent permitted by the Nevada Revised Statutes. Such indemnification does not include any claims resulting from the gross negligence or wilful misconduct of the Director. The indemnification provided for in this paragraph shall survive the Termination Date.

 

10. Successors; Assignment.

 

(a) The Company. This Agreement shall be binding upon and inure to the benefit of the Company and its successors and permitted assigns.

 

(b) The Director. Neither this Agreement, nor any right, obligation or interest hereunder, may be assigned by the Director, his beneficiaries, or his legal representatives without the prior written consent of the Company; provided, however, that nothing in this paragraph (b) shall preclude (i) the Director from designating a beneficiary to receive any benefit payable hereunder upon his death, or (ii) the executors, administrators, or other legal representatives of the Director or his estate from assigning any such rights hereunder to distributees, legatees, beneficiaries, testamentary trustees or other legal heirs of the Director. Subject to the foregoing, this Agreement shall be binding upon and inure to the benefit of the Director and his executors and administrators.

 

 
- 5 -

 

 

11. Waiver of Breach. The waiver by the Company or the Director of a breach of any provision of this Agreement by the other party shall not be construed as a waiver of any continuing or subsequent breach of the same provision or of any other provision of this Agreement. It is also understood and agreed that no failure or delay by the Company in exercising any right, power or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise thereof preclude any other or future exercise thereof or the exercise of any other right, power or privilege hereunder.

 

12. Notices. All notices and other communications hereunder shall be in writing and shall be deemed to have been given when delivered by hand or courier service, or mailed by first-class certified mail, postage prepaid and return receipt requested, addressed as follows:

 

 

If to the Company:

 

 

 

 

 

Amplitech Group, Inc.

Attn: Fawad Maqbool

620 Johnson Avenue

Bohemia, NY 11716

 

If to the Director:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

   

or, in each case, at such other address as may from time to time be specified to the other party in a notice similarly given.

 

13. Governing Law; Litigation.

 

(a) Governing Law. This Agreement shall be governed by end construed in accordance with the internal laws of the State of New York applicable to agreements made and to be performed entirely within such State.

 

(b) Litigation. Each of the Company and the Director hereby agrees that the courts of the State of New York shall have jurisdiction to hear and determine any claims or disputes pertaining to this Agreement or to any matter arising therefrom. Each of the Company and the Director expressly submits and consents in advance to such jurisdiction in any action commenced in such courts, hereby waiving personal service of the summons and complaint or other process or papers issued therein, and agreeing that service of such summons and complaint, or other process or papers, may be made in any manner permitted by the laws of the State of New York including if permissible the same manner as notices hereunder may be given pursuant to Section 10. The choice of forum set forth in this paragraph (b) shall not be exclusive nor shall it preclude the enforcement of any judgment obtained in such forum or the taking of any action under this Agreement to enforce such judgment in any appropriate jurisdiction.

 

 
- 6 -

 

  

14. Expenses. All costs and expenses (including attorneys’ fees) incurred in connection with the negotiation and preparation of, or any claim, dispute or litigation pertaining to, this Agreement shall be paid by the party incurring such expenses.

 

15. Entire Agreement. This Agreement contains the entire agreement of the parties and their affiliates relating to the subject matter hereof and thereof and supersedes all prior agreements, representations, warranties and understandings, written or oral, with respect thereto.

 

16. Severability.

 

(a) Generally. If any term or provision of this Agreement or the application thereof to any person, property or circumstance shall to any extent be invalid or unenforceable, the remainder of this Agreement, or the application of such term or provision to persons, property or circumstances other than those as to which it is invalid or unenforceable, shall not be affected thereby, and each term and provision of this Agreement shall be valid and enforceable to the fullest extent permitted by law.

 

(b) Duration and Scope of Certain Covenants. Without limiting paragraph (a) above, if any court determines that any of the covenants contained in Section 6, or any part of such covenants, is unenforceable because of the duration or scope of such covenant or provision, such court shall have the power to and is hereby requested to reduce the duration or scope of such covenant or provision, as the case may be, to the extent necessary to make such covenant or provision enforceable, and in its reduced form, such covenant or provision shall then be enforceable.

 

17. Remedies.

 

(a) Injunctive Relief. The Director acknowledges and agrees that the covenants and obligations of the Director contained in Section 6 relate to special, unique and extraordinary matters and are reasonable and necessary to protect the legitimate interests of the Company and that a breach of any of the terms of such covenants and obligations will cause the Company irreparable injury for which adequate remedies at law are not available. Therefore, the Director agrees that the Company shall be entitled to an injunction, restraining order, or other equitable relief from any court of competent jurisdiction restraining the Director from any such breach.

 

(b) Remedies Cumulative. The Company’s rights and remedies under this Section 15 are cumulative and are in addition to any other rights and remedies the Company may have at law or in equity. In connection with paragraph (a) of this Section 15, the Director represents that his economic means and circumstances are such that such provisions will not prevent him from providing for himself and his family on a basis satisfactory to him.

 

 
- 7 -

 

 

18. Waiver of Statute of Limitations. The Director hereby waives for the longest period permitted by applicable law the limitation of any statute for the presentation of any claim arising under any provision of Section 6 hereof.

 

19. Withholding Taxes. The Company shall deduct any foreign, federal, state or local withholding or other taxes from any payments to be made by the Company hereunder in such amounts which the Company reasonably determines are required to be deducted under applicable law.

 

20. Amendments, Miscellaneous, etc. Neither this Agreement, nor any term hereof, may be changed, waived, discharged or terminated except by an instrument in writing signed by the party against which such change, waiver, discharge or termination is sought to be enforced. This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, and all of which together shall constitute one and the same instrument. The headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement.

 

 
- 8 -

 

 

IN WITNESS WHEREOF, the parties hereto have duly executed and delivered this Agreement as of the date first written above.

 

  AMPLITECH GROUP, INC.
       
By:

 

Name:

Fawad Maqbool  
  Title:

Chief Executive Officer

 
       

 

DIRECTOR

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
- 9 -

 

 

EXHIBIT A

 

 

The Company is retaining the services of the Director as described in the [COMMITTEE NAME] Committee Charter.

 

 

 

 
- 10 -

 

EX-101.SCH 3 ampg-20220120.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 ampg-20220120_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Registrant Name Entity Central Index Key Document Type Amendment Flag Entity Emerging Growth Company Document Period End Date Entity Incorporation State Country Code Written Communications Soliciting Material Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Entity File Number Entity Address Address Line 1 Entity Address City Or Town Entity Address State Or Province Entity Address Postal Zip Code Local Phone Number City Area Code Security 12b Title Trading Symbol Security Exchange Name Entity Tax Identification Number EX-101.CAL 5 ampg-20220120_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.PRE 6 ampg-20220120_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.DEF 7 ampg-20220120_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE XML 8 R1.htm IDEA: XBRL DOCUMENT v3.21.4
Cover
Jan. 20, 2022
Cover [Abstract]  
Entity Registrant Name AmpliTech Group, Inc.
Entity Central Index Key 0001518461
Document Type 8-K
Amendment Flag false
Entity Emerging Growth Company false
Document Period End Date Jan. 20, 2022
Entity Incorporation State Country Code NV
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Entity File Number 000-54355
Entity Address Address Line 1 620 Johnson Avenue
Entity Address City Or Town Bohemia
Entity Address State Or Province NY
Entity Address Postal Zip Code 11716
Local Phone Number -521-7831
City Area Code 631
Security 12b Title Common Stock, par value $0.001 per share
Trading Symbol AMPG
Security Exchange Name NASDAQ
Entity Tax Identification Number 92-4566352
XML 9 ampg_8k_htm.xml IDEA: XBRL DOCUMENT 0001518461 2022-01-20 2022-01-20 iso4217:USD shares iso4217:USD shares 0001518461 false 8-K 2022-01-20 AmpliTech Group, Inc. NV 000-54355 92-4566352 620 Johnson Avenue Bohemia NY 11716 631 -521-7831 false false false false Common Stock, par value $0.001 per share AMPG NASDAQ false EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.4 html 1 118 1 false 0 0 false 3 false false R1.htm 000001 - Document - Cover Sheet http://ampg.com/role/Cover Cover Cover 1 false false All Reports Book All Reports ampg_8k.htm ampg-20220120.xsd ampg-20220120_cal.xml ampg-20220120_def.xml ampg-20220120_lab.xml ampg-20220120_pre.xml ampg_ex101.htm http://xbrl.sec.gov/dei/2020-01-31 true true JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ampg_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "calculationLink": { "local": [ "ampg-20220120_cal.xml" ] }, "definitionLink": { "local": [ "ampg-20220120_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "ampg_8k.htm" ] }, "labelLink": { "local": [ "ampg-20220120_lab.xml" ] }, "presentationLink": { "local": [ "ampg-20220120_pre.xml" ] }, "schema": { "local": [ "ampg-20220120.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd", "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 23, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 118, "memberCustom": 0, "memberStandard": 0, "nsprefix": "ampg", "nsuri": "http://ampg.com/20220120", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "ampg_8k.htm", "contextRef": "From2022-01-20to2022-01-20", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000001 - Document - Cover", "role": "http://ampg.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "strong", "p", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "ampg_8k.htm", "contextRef": "From2022-01-20to2022-01-20", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://ampg.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://ampg.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://ampg.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://ampg.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line 1" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://ampg.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://ampg.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://ampg.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://ampg.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://ampg.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://ampg.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://ampg.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://ampg.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://ampg.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://ampg.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://ampg.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://ampg.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://ampg.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://ampg.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://ampg.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://ampg.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://ampg.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://ampg.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 16 0001477932-22-000447-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001477932-22-000447-xbrl.zip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end